Affordable Access

Publisher Website

Activation of the mTOR pathway in primary medullary thyroid carcinoma and lymph node metastases.

Authors
Type
Published Article
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Publication Date
Volume
18
Issue
13
Pages
3532–3540
Identifiers
DOI: 10.1158/1078-0432.CCR-11-2700
PMID: 22753663
Source
Medline

Abstract

The AKT/mTOR pathway is activated in MTC, particularly, in LNMs. This pathway sustains malignant features of MTC cell models. These findings suggest that targeting mTOR might be efficacious in patients with advanced MTC.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments